Cardiologia

AHA: chamado para ação na doença cardiovascular em mulheres: epidemiologia, alertas, acesso e disponibilidade de cuidado de saúde equitativo.

12 Mai, 2022 | 15:21h

Call to Action for Cardiovascular Disease in Women: Epidemiology, Awareness, Access, and Delivery of Equitable Health Care: A Presidential Advisory From the American Heart Association – Circulation

Comunicado de imprensa: Investment, action urged to improve access, quality and equity in women’s heart health – American Heart Association

---

Revisão | O crescente papel do controle de ritmo cardíaco em pacientes com fibrilação atrial.

12 Mai, 2022 | 15:11h

The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review – Journal of the American College of Cardiology

Pontos principais: The Increasing Role of Rhythm Control in Atrial Fibrillation – American College of Cardiology

---

Revisão | Anticoagulação para choque cardiogênico apoiado por dispositivo de assistência ventricular percutânea.

12 Mai, 2022 | 15:10h

Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the Week – Journal of the American College of Cardiology

---

Revisão sistemática | Ecocardiografia transtorácica com Doppler para detecção de hipertensão pulmonar em adultos.

12 Mai, 2022 | 15:09h

Doppler trans‐thoracic echocardiography for detection of pulmonary hypertension in adults – Cochrane Library

Comentário: Doppler trans-thoracic echocardiography for detection of pulmonary hypertension in adults – Cochrane Library

---

Análise secundária de ensaios clínicos randomizados | Tempo para o benefício clínico da redução intensa da pressão arterial em pacientes hipertensos de 60 anos de idade ou mais.

12 Mai, 2022 | 14:37h

Time to Clinical Benefit of Intensive Blood Pressure Lowering in Patients 60 Years and Older With Hypertension: A Secondary Analysis of Randomized Clinical Trials – JAMA Internal Medicine

---

Síndrome do coração feliz: frequência, características e desfechos da síndrome de Takotsubo desencadeada por eventos positivos de vida.

12 Mai, 2022 | 14:31h

Happy Heart Syndrome: Frequency, Characteristics, and Outcome of Takotsubo Syndrome Triggered by Positive Life Events – JACC: Heart Failure (link para o resumo – $ para o texto completo)

Comentário: ‘Broken Heart Syndrome’ Also Linked to Happy Hearts – WebMD

---

Estudo randomizado | Monitoramento remoto e economia comportamental no tratamento da insuficiência cardíaca em pacientes pós-alta hospitalar.

12 Mai, 2022 | 14:28h

Remote Monitoring and Behavioral Economics in Managing Heart Failure in Patients Discharged From the Hospital: A Randomized Clinical Trial – JAMA Internal Medicine

Comentário: Remote Monitoring Not Successful at Reducing Death, Readmission From HF – AJMC

 

Comentários no Twitter

In this randomized clinical trial, a state-of-the-art intervention based in behavioral economics failed to prevent readmissions in patients discharged with heart failure. https://t.co/3pGxrJHpjd

— JAMA Internal Medicine (@JAMAInternalMed) May 9, 2022

 

---

Cárdio-obstetrícia: a próxima fronteira na prevenção da doença cardiovascular.

12 Mai, 2022 | 14:23h

Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention – Current Atherosclerosis Reports (se o acesso a este link for pago, tente este)

---

Tratamento da insuficiência cardíaca com fração de ejeção preservada: de antagonistas neuro-hormonais à empagliflozina.

12 Mai, 2022 | 14:21h

Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin – Heart Failure Reviews

---

Metanálise de estudos randomizados controlados | Momento da estratégia invasiva na síndrome coronariana aguda sem elevação do segmento ST.

10 Mai, 2022 | 14:25h

Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials – European Heart Journal

 

Comentário no Twitter

Timing of invasive management of NSTE-ACS: is the time up for early management?

Timing of invasive strategy in #NSTEMI : a meta-analysis of randomized controlled trialshttps://t.co/XD074Lh94S @ESC_Journals @escardio @mmamas1973 @ALEX_MISCHIE @AnkurKalraMD @HeartOTXHeartMD pic.twitter.com/0XekZqvJop

— Henry Han, MBBS, MD (@HanCardiomd) May 6, 2022

Sob a licença de https://creativecommons.org/licenses/by-nc/4.0/

---